CANDESARTAN CILEXETIL

Product NDC
46708-343
11-digit product format
467080343
Labeler code
46708
Product ID
46708-343_aaa63206-6c7d-4996-8991-91bfdb69b821
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
CANDESARTAN CILEXETIL
Dosage form
TABLET
Route
ORAL
Labeler
Alembic Pharmaceuticals Limited
Application
ANDA210302
Marketing category
ANDA
Marketing start
2018-12-05
Substance
CANDESARTAN CILEXETIL
Active strength
16 mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A210302-001CANDESARTAN CILEXETILCANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04
A210302-002CANDESARTAN CILEXETILCANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04
A210302-003CANDESARTAN CILEXETILCANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-productTE code
A210302-001AB
A210302-002AB
A210302-003AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-0431067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-046a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-0403ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-0403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-042680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-042680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-045bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-045bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04d06236e962d9…
2024-10-29 15:01 UTC2024-10A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04d06236e962d9…
2024-10-29 15:01 UTC2024-10A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-0479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-0479d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-0479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-04301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-04301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-04301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-041e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210302-002CANDESARTAN CILEXETIL8MGTABLET / ORALAB2018-12-041e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210302-003CANDESARTAN CILEXETIL16MGTABLET / ORALAB2018-12-041e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210302-001CANDESARTAN CILEXETIL4MGTABLET / ORALAB2018-12-048072bd15b7f6…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 123 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A210302-001AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210302-002AB1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A210302-003AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210302-001AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210302-002AB131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A210302-003AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A210302-001AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210302-002AB16a471c1ec25d…
2025-08-23 18:47 UTC2025-08A210302-003AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210302-001AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210302-002AB1fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A210302-003AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210302-001AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210302-002AB1b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A210302-003AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210302-001AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210302-002AB103ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A210302-003AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210302-001AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210302-002AB12680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A210302-003AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210302-001AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210302-002AB15bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A210302-003AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210302-001AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210302-002AB1d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A210302-003AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A210302-001AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A210302-002AB1d06236e962d9…
2024-10-29 15:01 UTC2024-10A210302-003AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210302-001AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210302-002AB179d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A210302-003AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210302-001AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210302-002AB1301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A210302-003AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210302-001AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210302-002AB11e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A210302-003AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A210302-001AB18072bd15b7f6…

Additional Listing Data#

Finished product
Yes
Brand name base
CANDESARTAN CILEXETIL
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CANDESARTAN CILEXETIL16 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
R85M2X0D68Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 3 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
153822Internal RxNorm lookup
153823Internal RxNorm lookup
577776Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d5b43fa0-6678-4219-99f1-10d273d49bafAvailable on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
03f056e9-4354-02cc-6010-79c6c9eaac0aProduct name620250521
00fc2cf9-672f-3e0b-6afa-43cbc864d058Product name420180613

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDCEffectiveRelated label
46708-343-302023-01-31These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 1998
46708-343-902023-01-31These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 1998
46708-343-912023-01-31These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 1998
46708-343-302023-01-30These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 1998
46708-343-902023-01-30These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 1998
46708-343-912023-01-30These highlights do not include all the information needed to use CANDESARTAN CILEXETIL TABLETS safely and effectively. See full prescribing information for CANDESARTAN CILEXETIL TABLETS. CANDESARTAN CILEXETIL tablets, for oral use INITIAL U.S. APPROVAL: 1998

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
46708-343-30CANDESARTAN CILEXETIL30 in 1 BOTTLETABLET304
46708-343-90CANDESARTAN CILEXETIL90 in 1 BOTTLETABLET904
46708-343-91CANDESARTAN CILEXETIL1000 in 1 BOTTLETABLET10004

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
46708-343CANDESARTAN CILEXETIL TABLET [ALEMBIC PHARMACEUTICALS LIMITED]4Current NDC, Legacy NDC, 3 package rows20230202_d5b43fa0-6678-4219-99f1-10d273d49baf.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
CANDESARTAN CILEXETILCANDESARTAN CILEXETILBryant Ranch Prepack9afc130e-a784-49fe-9772-27c492724f082023-09-25Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210302
application number: ANDA210302
CANDESARTAN CILEXETILCANDESARTAN CILEXETILAlembic Pharmaceuticals Limitedd5b43fa0-6678-4219-99f1-10d273d49baf2023-01-27Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210302
application number: ANDA210302
ndc (product): 46708-343
CANDESARTAN CILEXETILCANDESARTAN CILEXETILAlembic Pharmaceuticals Inc.8a515af5-bd53-43f1-b40a-aa0f332bc2ab2021-09-30Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (ANDA): 210302
application number: ANDA210302

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
577776candesartan cilexetil 16 MG Oral TabletPSNd5b43fa0-6678-4219-99f1-10d273d49baf4
153822candesartan cilexetil 4 MG Oral TabletPSNd5b43fa0-6678-4219-99f1-10d273d49baf4
153823candesartan cilexetil 8 MG Oral TabletPSNd5b43fa0-6678-4219-99f1-10d273d49baf4
577776candesartan cilexetil 16 MG Oral TabletSCDd5b43fa0-6678-4219-99f1-10d273d49baf4
153822candesartan cilexetil 4 MG Oral TabletSCDd5b43fa0-6678-4219-99f1-10d273d49baf4
153823candesartan cilexetil 8 MG Oral TabletSCDd5b43fa0-6678-4219-99f1-10d273d49baf4

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
46708-343-304670803433030 TABLET in 1 BOTTLE (46708-343-30) 30 tablet2018-12-050000-00-00NoNoCurrent
46708-343-904670803439090 TABLET in 1 BOTTLE (46708-343-90) 90 tablet2018-12-050000-00-00NoNoCurrent
46708-343-91467080343911000 TABLET in 1 BOTTLE (46708-343-91) 1000 tablet2018-12-050000-00-00NoNoCurrent